Chinese Journal of Blood Purification ›› 2024, Vol. 23 ›› Issue (03): 197-199,218.doi: 10.3969/j.issn.1671-4091.2024.03.009

Previous Articles     Next Articles

Advances in the diagnosis and treatment of encapsulated peritoneal sclerosis in peritoneal dialysis patients

LOU Fang-fang, LIU Xiao-yi, XIE Chao, KONG Yao-zhong   

  1. Department of Nephrology, Foshan First People's Hospital, Guangdong 528000, China
  • Received:2023-09-21 Revised:2023-12-19 Online:2024-03-12 Published:2024-03-12
  • Contact: 528000 广东,1佛山市第一人民医院肾内科 E-mail:kyzhong@fsyyy.com

Abstract: Peritoneal dialysis (PD) is now widely used in the long-term treatment of patients with end stage renal disease (ESRD). Encapsulating peritoneal sclerosis (EPS) is a rare and serious complication of long-term PD patients with a high morbidity and mortality rate. The clinical symptoms of EPS mainly include irregular, persistent or frequent gastrointestinal obstruction symptoms often accompanied by severe abdominal pain, nausea, and vomiting. Imaging mostly shows progressive fibrotic thickening and sclerosis of the peritoneum, leading to intestinal encapsulation and followed by partial or complete intestinal obstruction. The purpose of this review is to introduce the pathogenesis of EPS and the progress of its diagnosis and treatment.

Key words: Peritoneal dialysis, Encapsulating peritoneal sclerosis, Pathogenesis, Diagnosis, Treatment

CLC Number: